Scancell Holdings extends collaboration with Sweden's Karolinska Institute
The company first teamed up with Sweden's world-leading medical research university two years ago
Company
LON:SCLP
Scancell is a clinical stage biotech company developing immunotherapies for a cancer-free future by enhancing long-lasting tumour specific immunity. With deep roots in cancer immunology and translational research, the company aims to translate its innovation and creativity to address the need for fast, potent and accessible therapies that are easy to administer in hard-to-treat cancers.
329 stories · page 10 of 17
The company first teamed up with Sweden's world-leading medical research university two years ago
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Companies covered today include 88 Energy, Bagir Group, Future, Mpac, NAHL, Quadrise Fuels and Smiths Group
It has exercised an option on TriGrid, which was developed by Ichor Medical Systems
Investments and investor services
The index of leading UK shares closed up just shy of 50 points higher at 7,676, while the FTSE 250 was also up
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the main news-driven risers and fallers in London on Wednesday afternoon ...
The patent protects a new class of cancer vaccines rolling off the Moditope platform
Investments and investor services
Global markets are in the red after Donald Trump said he was not happy with the progress of talks with China.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London on Tuesday
FTSE 100 closed 1.39 points lower at 7,565, while FTSE 250 went the other way
Archive
A look back at some of the more interesting from the junior market this week
Oil prices have recovered over the past year which has led to companies setting up more rigs; good news for Enteq, an oilfield services provider
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at some of the biggest risers and fallers in London on Tuesday
The AIM-listed firm said its Moditope platform acts by stimulating the production of CD4+ T cells, which seek out and kill tumour cells that would otherwise be hidden from the immune system
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of today's top risers and fallers in London